Risk-sharing alliance on tailor-made phenotypic models for IBD and HBV Upfront payment and milestone payments for MIMETAS Access to know-how on novel disease models and assays for Roche Option to exclusively license of disease models and assays for Roche LEIDEN, The Netherlands -- MIMETAS, a leader in organ-on-chip-based disease models and technology, and Roche, a world-leading pharmaceutical [...]

SAN DIEGO -- Bionano Genomics, Inc. (Nasdaq: BNGO) announced significant progress in China with the adoption of its Saphyr® System for optical genome mapping (OGM) by WeHealth Shanghai, a leading provider of genome analysis services in reproductive health. The adoption was announced at the Structural Variation Symposium in Shanghai, organized with support from the Shanghai [...]

Chicago/Boston — GE Healthcare and SOPHiA GENETICS today announced that they have signed a letter of intent to collaborate on advancing cancer care, with the goal of better targeting and matching treatments to each patient’s genomic profile and cancer type, helping to ensure the most effective and personalized treatment. The companies aim to develop new artificial intelligence (AI)-powered [...]

Christian Brönnimann strengthens the DECTRIS management in January 2022 by handing over the CEO’s mantle to CTO Matthias Schneebeli. The decision is only one example of a company-wide trend to distribute responsibilities and leadership, and it’s a natural next growth move after the company delivered a record-high number of X-ray and electron detectors in 2020. Dr. [...]

NEW YORK & BOULDER, Colo. -- CM Life Sciences II (NASDAQ: CMIIU) and SomaLogic, Inc., a global leader in proteomics technology, announced today that their new customizable protein panel products are now available to pharma, biotechnology and academic research customers seeking the power of the company’s proteomics menu of 7,000 proteins. "Our customers have expressed [...]

Göttingen Portfolio expanded by cell culture components, such as growth factors, cytokines, and media CellGenix site in Freiburg to be expanded into a center of excellence for the development and production of cell culture components The life science group Sartorius, through its subgroup Sartorius Stedim Biotech, has acquired a majority stake in the reagent manufacturer [...]

Techcomp Instruments Limited (“Techcomp”) is delighted to announce that Techcomp Europe has successfully completed the acquisition of a majority shareholding in Isotopx Limited, based in Middlewich, Cheshire. For the past 13 years Isotopx has been at the forefront of mass spectrometer design and innovation. The whole team at Isotopx, led by CEO and founder Zenon [...]

Manufacturing partnership enables suspension-based manufacture of gene therapies and viral vector-based vaccines PORT WASHINGTON, N.Y. – Pall Corporation, a global leader in filtration, separation and purification, today announced a new contract worth more than $7M with full-service contract development and manufacturing organization (CDMO) Exothera S.A. The new contract with Pall will establish a suspension-based manufacturing platform [...]

Metrohm DropSens announces high-volume manufacturing capability for custom sensors Metrohm DropSens has announced new capabilities that facilitate the high-volume production of customized electrochemical sensors. Custom sensors are manufactured through a highly scalable and cost-effective manufacturing process with virtually no quantity limits. Metrohm DropSens supports the entire development and production process, from initial conceptualization to in-depth prototype [...]

License agreement to enhance Nippon Gene’s CRISPR/Cas9 research reagents offering Dublin, Ireland and Tokyo, Japan, 01 July 2021: ERS Genomics Limited, which was formed to provide broad access to the foundational CRISPR/Cas9 intellectual property co-owned by Dr. Emmanuelle Charpentier, and Nippon Gene Co., Ltd (Nippon Gene), a manufacturer of genetic engineering research reagents and diagnostic reagents [...]